logo
Select company
Select metric
$ 6.05MNet Cash Flow - Financing
VS
Market
37
Sector
50
Industry
60
History
23
$ 0.86Close
$ 0.79 - $ 3.1 52-Week Range
Ticker Information

Ticker

LEXX

Company Name

LEXARIA BIOSCIENCE CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

LEXARIA BIOSCIENCE CORP - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LEXX - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ 6.05M
3/31/2025$ 9.4M
12/31/2024$ 12.84M
9/30/2024$ 10.32M
6/30/2024$ 10.19M
3/31/2024$ 6.86M
12/31/2023$ 3.42M
9/30/2023$ 1.59M
6/30/2023$ 1.7M
3/31/2023$ -22.41K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LEXARIA BIOSCIENCE CORP's latest trailing twelve months (TTM) CF - Financing stands at $ 2.7M.
  • Over the past 5 years, LEXARIA BIOSCIENCE CORP's average CF - Financing has been $ 6.12M.
  • The median CF - Financing for LEXARIA BIOSCIENCE CORP during this period was $ 5M
  • LEXARIA BIOSCIENCE CORP reached its highest CF - Financing over the past 5 years at $ 13.42M.
  • The lowest CF - Financing recorded by LEXARIA BIOSCIENCE CORP in the same timeframe $ -44.82K

LEXARIA BIOSCIENCE CORP's CF - Financing vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Financing Benchmarks
CompanyCF - Financing
BRTX : BIORESTORATIVE THERAPIES INC $ 1.85MIBIO : IBIO INC $ 8.93MERNA : ERNEXA THERAPEUTICS INC $ 12.08MICU : SEASTAR MEDICAL HOLDING CORP $ 20.48MRLYB : RALLYBIO CORP $ 17KLYRA : LYRA THERAPEUTICS INC $ 4.62MPULM : PULMATRIX INC $ 0VYNE : VYNE THERAPEUTICS INC $ -255KAPRE : APREA THERAPEUTICS INC $ 573.98KMGRX : MANGOCEUTICALS INC $ 5.44M

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

LEXX - Net Cash Flow - Financing, Last 5 years

$ -44.82K

Minimum

Dec 31, 2022

$ 13.42M

Maximum

Sep 30, 2021

$ 6.12M

Average

$ 5M

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.84M with a standard deviation of $ 119.27M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.22K
min$ -367.1M
max$ 366M
average$ -6.84M
median$ 305K
std$ 119.27M